Your browser doesn't support javascript.
loading
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Wang, Xin Shelley; Srour, Samer A; Mendoza, Tito; Whisenant, Meagan; Subbiah, Ishwaria; Gonzalez, Elizabeth; Kamal, Mona; Shen, Shu-En; Cleeland, Charles; Kebriaei, Partow; Rezvani, Katayoun; Neelapu, Sattva; Ahmed, Sairah; Shpall, Elizabeth.
Afiliação
  • Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mendoza T; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Whisenant M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Subbiah I; Department of Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Gonzalez E; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kamal M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shen SE; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kebriaei P; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Neelapu S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ahmed S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Br J Haematol ; 201(4): 738-746, 2023 05.
Article em En | MEDLINE | ID: mdl-36733986
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article